Financhill
Back

New York Times Vs. Cidara Therapeutics Industry Stock Comparison

Buy
70

NYT
New York Times

Last Price:
$54.76
Seasonality Move:
-2.47%
Buy
77

CDTX
Cidara Therapeutics

Last Price:
$52.39
Seasonality Move:
-8.55%
Buy
70
New York Times (NYT) is a Buy

Is New York Times a Buy, Sell or Hold?

  • The current New York Times [NYT] share price is $56.18. The Score for NYT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • NYT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy, Sell or Hold?

  • The current Cidara Therapeutics [CDTX] share price is $55.32. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NYT Stock Price Chart

What is New York Times's stock price today?

  • The New York Times share price today is $56.18
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics's stock price today?

  • The Cidara Therapeutics share price today is $55.32
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 13.86 Buy
Relative Strength Index (14 RSI): 54.93 Buy
Chaikin Money Flow: 601274 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.89 - 56.45) Buy
Bollinger Bands (100): (48.53 - 55.45) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.91 Buy
Relative Strength Index (14 RSI): 81.84 Buy
Chaikin Money Flow: 1154906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.31 - 51.77) Buy
Bollinger Bands (100): (15.88 - 36.04) Buy

NYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.37 Sell
20-day SMA: 55.68 Buy
50-day SMA: 55.2 Buy
200-day SMA: 52.95 Buy
8-day EMA: 40.16 Buy
20-day EMA: 22.11 Buy
50-day EMA: 10.18 Buy
200-day EMA: 2.74 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.39 Buy
20-day SMA: 42.46 Buy
50-day SMA: 30.72 Buy
200-day SMA: 21.84 Buy
8-day EMA: 50.49 Buy
20-day EMA: 44.06 Buy
50-day EMA: 34.72 Buy
200-day EMA: 23.97 Buy

New York Times Earnings Growth & NYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.06 per share, an increase this year of $0.28 per share, and an increase next year of $0.21 per share.

Cidara Therapeutics Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.

New York Times Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):